术后即刻促甲状腺激素测定作为促甲状腺激素分泌型垂体腺瘤缓解的早期预测指标
该单中心回顾性研究分析2005至2017年连续31例促甲状腺激素分泌型垂体腺瘤(TSHoma)的手术与内分泌结局,评估术前及术后早期因素对长期内分泌缓解的预测价值。结果示全切除28例(90.3%)、单纯手术内分泌缓解26例(83.9%),术后12小时TSH水平为最强预测因子(截断值0.62 μIU/mL)。
要点
- 31例TSHoma中全切除28例(90.3%),单纯手术长期内分泌缓解26例(83.9%)。
- 肿瘤较大及侵犯海绵窦、蝶窦是内分泌缓解率较低的强预测因素。
- 术后12小时TSH水平为最强预测因子,截断值0.62 μIU/mL。
核心结论
- 肿瘤大小和范围是切除范围与内分泌缓解的主要预后因素,TSHoma长期缓解可在术后早期预测。
研究设计与样本
- 单中心回顾性研究,连续纳入2005至2017年手术治疗的31例TSHoma,回顾临床、影像、病理及手术与内分泌结局。
主要发现
- 全切除28例(90.3%),单纯手术内分泌缓解26例(83.9%),长期内分泌随访中位50个月(范围32-81个月)。
- 肿瘤多数为实性(21/31,67.7%),16例(51.6%)可整块切除。
- 术后12小时TSH水平为最强预测因子,截断值0.62 μIU/mL。
- 术后并发症包括脑脊液鼻漏1例和鼻出血1例,后者因并发症接受再次手术治疗。
关键数值与推荐
- 术后12小时TSH水平预测长期内分泌缓解的截断值为0.62 μIU/mL。
临床怎么用
- 作者认为TSHoma长期缓解可在术后早期预测,术后12小时TSH水平可用于预测长期内分泌缓解。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) is a rare type of pituitary adenoma; thus, little is known about TSHomas. The purpose of this study was to analyze clinical characteristics and therapeutic outcomes of TSHomas based on a single-center experience. The authors also searched for reliable preoperative and early postoperative factors that could predict long-term endocrinological remission. METHODS: The clinical, radiological, and pathological characteristics and surgical and endocrinological outcomes of 31 consecutive cases of TSHomas that were surgically treated between 2005 and 2017 were reviewed retrospectively. Preoperative factors were evaluated for their ability to predict long-term remission by comparing remission and nonremission groups. TSH and free thyroxine levels were measured at 2, 6, 12, 18, and 24 hours after surgery to determine whether they could predict long-term remission. RESULTS: Gross-total removal of tumor was achieved in 28 patients (90.3%), and 26 patients (83.9%) achieved endocrinological remission by surgery alone based on long-term endocrinological follow-up (median 50 months, range 32-81 months). The majority of the tumors were solid (21/31, 67.7%), and en bloc resection was possible in 16 patients (51.6%). Larger tumor size and tumor invasion into cavernous sinus and sphenoid sinus were strong predictors of lower rates of endocrinological remission. Immediate postoperative TSH level at 12 hours after surgery was the strongest predictor, with a 0.62 μIU/mL cutoff. Postoperative complications included CSF rhinorrhea in one patient and epistaxis in another patient, who underwent additional surgical treatment for the complications. CONCLUSIONS: Tumor size and extent are major prognostic factors for both extent of resection and endocrinological remission. The consistency of TSHomas was more likely to be solid, which makes extracapsular dissection more feasible. Long-term remission of TSHomas could be predicted even during the early postoperative period.
引用
- Kim SH, Ku CR, Na M, et al. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas. J Neurosurg. 2020. PMID: 32168476. doi:10.3171/2020.1.JNS192787
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。